Argon to pay $362.5M for Angiotech's interventional biz

Argon Medical Devices has agreed to pay $362.5 million to acquire Angiotech Pharmaceuticals' interventional products unit. The cash deal, set to be finalized by the end of next month, covers Angiotech's drainage catheters, biopsy systems and related products.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT